(FHI) Federated Investors - Overview
Stock: Mutual Funds, Separate Accounts, Money Market, Fixed Income, Equity
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.60% |
| Yield on Cost 5y | 5.61% |
| Yield CAGR 5y | 5.34% |
| Payout Consistency | 87.9% |
| Payout Ratio | 26.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 21.2% |
| Relative Tail Risk | 3.19% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.32 |
| Alpha | 24.72 |
| Character TTM | |
|---|---|
| Beta | 0.729 |
| Beta Downside | 0.798 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.61% |
| CAGR/Max DD | 0.48 |
Description: FHI Federated Investors January 12, 2026
Federated Hermes, Inc. (NYSE:FHI) is a publicly traded investment manager that serves a broad client base-including high-net-worth individuals, institutions, pension plans, and charitable organizations-through a suite of equity, fixed-income, balanced, and money-market mutual funds and separate accounts. The firm operates globally, investing in growth and value stocks across small-, mid- and large-cap segments, as well as a diversified range of fixed-income securities such as mortgage-backed, government, corporate, high-yield, and municipal bonds.
As of the most recent filing, Federated Hermes reported approximately **$620 billion** in assets under management (AUM), with a **5.2% year-over-year increase** driven primarily by inflows into its ESG-focused strategies. The company generated **$1.9 billion** in revenue and **$260 million** in net income for the trailing twelve months, reflecting a **14% operating margin** despite ongoing fee-compression pressures in the asset-management industry.
Key sector drivers affecting Federated Hermes include: (1) the **shift toward low-cost, passive and ESG-aligned products**, which is reshaping fee structures; (2) the **interest-rate environment**, where rising rates have boosted yields on newly issued fixed-income securities but also increased portfolio duration risk; and (3) **regulatory trends** that favor greater transparency and fiduciary standards, potentially expanding demand for actively managed solutions that demonstrate robust risk-adjusted performance.
For a deeper quantitative breakdown of Federated Hermes’ valuation metrics and scenario analysis, you may find it useful to explore the firm’s profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 404.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -10.64 > 1.0 |
| NWC/Revenue: 22.78% < 20% (prev 30.16%; Δ -7.38% < -1%) |
| CFO/TA 0.06 > 3% & CFO 136.1m > Net Income 404.1m |
| Net Debt (-375.9m) to EBITDA (562.5m): -0.67 < 3 |
| Current Ratio: 2.31 > 1.5 & < 3 |
| Outstanding Shares: last quarter (73.8m) vs 12m ago -5.75% < -2% |
| Gross Margin: 69.18% > 18% (prev 0.67%; Δ 6851 % > 0.5%) |
| Asset Turnover: 83.48% > 50% (prev 78.29%; Δ 5.19% > 0%) |
| Interest Coverage Ratio: 43.04 > 6 (EBITDA TTM 562.5m / Interest Expense TTM 9.53m) |
Altman Z'' 6.87
| A: 0.18 (Total Current Assets 724.3m - Total Current Liabilities 314.1m) / Total Assets 2.23b |
| B: 0.66 (Retained Earnings 1.46b / Total Assets 2.23b) |
| C: 0.19 (EBIT TTM 410.2m / Avg Total Assets 2.16b) |
| D: 2.14 (Book Value of Equity 2.07b / Total Liabilities 965.9m) |
| Altman-Z'' Score: 6.87 = AAA |
What is the price of FHI shares?
Over the past week, the price has changed by -1.54%, over one month by -1.26%, over three months by +5.96% and over the past year by +36.93%.
Is FHI a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 6
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the FHI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 54.7 | 5% |
| Analysts Target Price | 54.7 | 5% |
| ValueRay Target Price | 62.1 | 19.1% |
FHI Fundamental Data Overview February 07, 2026
P/E Forward = 10.4275
P/S = 2.2549
P/B = 3.4441
P/EG = 1.0361
Revenue TTM = 1.80b USD
EBIT TTM = 410.2m USD
EBITDA TTM = 562.5m USD
Long Term Debt = 348.3m USD (from longTermDebt, two quarters ago)
Short Term Debt = 18.2m USD (from shortTermDebt, two quarters ago)
Debt = 348.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -375.9m USD (from netDebt column, last quarter)
Enterprise Value = 3.68b USD (4.06b + Debt 348.4m - CCE 724.3m)
Interest Coverage Ratio = 43.04 (Ebit TTM 410.2m / Interest Expense TTM 9.53m)
EV/FCF = 27.71x (Enterprise Value 3.68b / FCF TTM 133.0m)
FCF Yield = 3.61% (FCF TTM 133.0m / Enterprise Value 3.68b)
FCF Margin = 7.38% (FCF TTM 133.0m / Revenue TTM 1.80b)
Net Margin = 22.44% (Net Income TTM 404.1m / Revenue TTM 1.80b)
Gross Margin = 69.18% ((Revenue TTM 1.80b - Cost of Revenue TTM 555.0m) / Revenue TTM)
Gross Margin QoQ = 74.66% (prev 69.21%)
Tobins Q-Ratio = 1.65 (Enterprise Value 3.68b / Total Assets 2.23b)
Interest Expense / Debt = 0.91% (Interest Expense 3.18m / Debt 348.4m)
Taxrate = 23.44% (32.9m / 140.3m)
NOPAT = 314.1m (EBIT 410.2m * (1 - 23.44%))
Current Ratio = 2.31 (Total Current Assets 724.3m / Total Current Liabilities 314.1m)
Debt / Equity = 0.29 (Debt 348.4m / totalStockholderEquity, last quarter 1.20b)
Debt / EBITDA = -0.67 (Net Debt -375.9m / EBITDA 562.5m)
Debt / FCF = -2.83 (Net Debt -375.9m / FCF TTM 133.0m)
Total Stockholder Equity = 1.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 18.73% (Net Income 404.1m / Total Assets 2.23b)
RoE = 35.33% (Net Income TTM 404.1m / Total Stockholder Equity 1.14b)
RoCE = 27.50% (EBIT 410.2m / Capital Employed (Equity 1.14b + L.T.Debt 348.3m))
RoIC = 21.31% (NOPAT 314.1m / Invested Capital 1.47b)
WACC = 7.98% (E(4.06b)/V(4.41b) * Re(8.60%) + D(348.4m)/V(4.41b) * Rd(0.91%) * (1-Tc(0.23)))
Discount Rate = 8.60% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.12%
[DCF Debug] Terminal Value 79.53% ; FCFF base≈218.2m ; Y1≈240.2m ; Y5≈308.4m
Fair Price DCF = 73.92 (EV 5.36b - Net Debt -375.9m = Equity 5.73b / Shares 77.5m; r=7.98% [WACC]; 5y FCF grow 11.61% → 2.90% )
EPS Correlation: 43.38 | EPS CAGR: 24.56% | SUE: 0.67 | # QB: 0
Revenue Correlation: 87.28 | Revenue CAGR: 11.15% | SUE: 1.27 | # QB: 2
EPS next Quarter (2026-03-31): EPS=1.18 | Chg30d=+0.031 | Revisions Net=+0 | Analysts=6
EPS current Year (2026-12-31): EPS=5.16 | Chg30d=+0.056 | Revisions Net=-2 | Growth EPS=+0.7% | Growth Revenue=+8.6%
EPS next Year (2027-12-31): EPS=5.70 | Chg30d=+0.062 | Revisions Net=-3 | Growth EPS=+10.4% | Growth Revenue=+4.2%